Entrada Therapeutics, Inc. (TRDA)
$4.86-11.64%Close
SELLCRISIS · day 15
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $189M
- Beta
- -0.24
- P/E (TTM)
- -1.22
- Short % float
- 13.46%
- Days to cover
- 9.9
- SI change
- +8.9%
- 1W
- -10.33%
- 1M
- -31.06%
- vs SPY 1W
- -10.19%
- vs SPY 1M
- -33.57%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on TRDA?
- LOPJLB’s latest quantitative signal on Entrada Therapeutics, Inc. (TRDA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TRDA in?
- Entrada Therapeutics, Inc. (TRDA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Entrada Therapeutics, Inc. (TRDA) do?
- Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches. Its foremost product…